CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Vcanbio Cell & Gene Engineering Corp Ltd Company Snapshot
Vcanbio Cell & Gene Engineering Corp Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vcanbio Cell & Gene Engineering Corp Ltd with three other companies in this sector in CHINA : Jinyu Bio-Technology Co Ltd (2020 sales of 1.58 billion Chinese Renmimbi [US$246.10 million] of which 96% was Bio-Pharmaecutical), Beijing SL Pharmaceutical Co Ltd (1.11 billion Chinese Renmimbi [US$173.11 million] of which 98% was Pharmaceuticals Industry), and Pacific Shuanglin Bio pharmacy Co Ltd (1.05 billion Chinese Renmimbi [US$163.34 million] of which 99% was Pharmaceutical Sales).

Sales Analysis. During the second quarter of 2021, sales at Vcanbio Cell & Gene Engineering Corp Ltd totalled 396.66 million Chinese Renmimbi. This is an increase of 15.9% from the 342.35 million Chinese Renmimbi in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled 767.05 million Chinese Renmimbi, which is 23.6% higher than through the first two quarters of 2020. During the year ended December of 2020, sales at Vcanbio Cell & Gene Engineering Corp Ltd were 1.32 billion Chinese Renmimbi (US$204.88 million). This is a decrease of 4.9% versus 2019, when the company's sales were 1.38 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 12.7% decline in Services, from 548.33 million Chinese Renmimbi to 478.58 million Chinese Renmimbi. There were also decreases in sales in Other Operations (down 4.2% to 31.38 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Manufacturing (up 0.4% to 808.94 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Vcanbio Cell & Gene Engineering Corp Ltd
  Stock Performance Chart for Vcanbio Cell & Gene Engineering Corp Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/8/2021): 23.33
(Figures in Chinese Renmimbi)
1 Week -2.5%   13 Weeks 3.2%  
4 Weeks 9.1%   52 Weeks -7.7%  
 
Vcanbio Cell & Gene Engineering Corp Ltd Key Data:
  Ticker: 600645 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 1,316,981,782
(Year Ending Jan 2021).
Employees: 2,233
  Currency: Chinese Renmimbi Market Cap: 10,917,247,604
  Fiscal Yr Ends: December Shares Outstanding: 467,948,890
  Share Type: A Gu Closely Held Shares: 171,776,794
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.